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doi:10.1Objective: This study evaluated long-term results of thoracic endovascular aortic repair for atherosclerotic an-
eurysms involving descending aorta.
Methods: One hundred thirteen patients underwent thoracic endovascular aortic repair for this indication from
1996 to 2009. Mean follow-up was 54  38 months (5–144 months). In-hospital mortality, neurologic injury,
need for rerouting, occurrence of endoleaks and their treatment, and survival were recorded.
Results: In-hospital mortality was 5.3%. Transient neurologic injury rate was 2.6%. Previous rerouting was
performed in 51%. Assisted early and late type I and III endoleak rates were 7.9% and 5.7%, respectively.
Five percent of patients required late surgical conversion. Actuarial survivals were 86%, 60%, and 42% at 1,
5, and 10 years, respectively. Aorta-related actuarial survivals were 94%, 90%, and 83% at 1, 5, and 10 years,
respectively. Cox regression analysis revealed higher number of prostheses as independent risk factor for early
(hazard ratio, 5.38; 95% confidence interval, 1.68–42.37) and late (hazard ratio, 8.49; 95% confidence interval,
1.09–66.06) endoleak formation. Female sex (hazard ratio, 0.35; 95% confidence interval, 0.13–0.99), no arch in-
volvement (hazard ratio, 0.21; 95% confidence interval, 0.05–0.08), and higher number of prostheses (hazard ratio,
7.95; 95% confidence interval, 1.36–46.58) affected survival.
Conclusions: Aorta-related survival is excellent among patients undergoing thoracic endovascular aortic repair
for atherosclerotic aneurysms involving the descending aorta. Life-long surveillance remains mandatory, with
early and late failure uncommon but still needing consideration. Thoracic endovascular aortic repair in this group
of patients remains attractive and has now proven durability. (J Thorac Cardiovasc Surg 2010;140:S179-84)Thoracic endovascular aortic repair (TEVAR) has changed
attitudes toward treating thoracic aortic disease and has
broadened options for patients with acute and chronic tho-
racic aortic pathologies.1-7 This has led to a multiplicity of
reports on feasibility as well as on short-term and midterm re-
sults regarding durability.8-11 No data are available, however,
regarding long-term results of this treatment modality. Such
data are strongly needed to discover the mechanisms of
both success and failure, to provide recommendations regard-
ing potential broader implementation of the technique, and to
put the technique into perspective. This study evaluated long-
term results of TEVAR for atherosclerotic aneurysms involv-
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The Journal of Thoracic and CardMATERIALS AND METHODS
Between 1996 and 2009, a total of 274 patients underwent TEVAR for
acute and chronic aortic disease in our department. One hundred thirteen
consecutive patients underwent TEVAR for atherosclerotic aneurysms
involving the descending aorta. No patients with diagnosed or suspected
connective tissue disorders were included in this series because we consid-
ered such disorders to be a contraindication to TEVAR, except for bail-out
procedures. Demographic characteristics and clinical risk factors are
shown in Table 1. Surgical access was gained through the common femo-
ral artery in 63% of cases. In the remaining patients, alternate access sites
were chosen (common iliac artery 35% and infrarenal aorta 2%). The
institutional review board approved the study and waived the need for
patient consent.Data Collection and Follow-up Protocol
Data were prospectively collected. Patients were subjected to a strict
follow-up protocol that required a contrast spiral computed tomographic
scan and both clinical and laboratory evaluations at 3, 6, and 12 months after
TEVAR and then annually thereafter. Endoleaks were defined according to
reporting standards.12,13Operative Procedure and Stent–Graft Systems Used
Preoperative rerouting procedures were performed to achieve a suffi-
cient proximal or distal landing zone of at least 2 cm. Procedures were per-
formed metachronously, with an interval of 1 week between rerouting and
TEVAR. Seven different commercially available stent–graft systems
were used. The types of stent–grafts and the frequencies of their use are
depicted in Table 2.iovascular Surgery c Volume 140, Number 6S S179
TABLE 1. Demographic characteristics and clinical risk factors
Age (y, median and interquartile range) 73 (67–77)
Female (%) 30%
Mean aneurysm diameter (cm, median and
interquartile range)
6.6 (6.0-7.2)
Proximal landing zone (cm, median and interquartile range) 3.0 (2.0-5.0)
Distal landing zone (cm, median and interquartile range) 5.0 (3.0-5.0)
Suitable for conventional surgery (%) 16%
Additive EuroSCORE (median and interquartile range) 9 (7-11)
Logistic EuroSCORE (median and interquartile range) 15 (10-28)
Chronic obstructive pulmonary disease (%) 50%
Coronary artery disease (%) 31%
Previous infrarenal aortic replacement (%) 12%
Renal insufficiency (%) 11%
Diabetes mellitus (%) 8%
Previous ascending aortic replacement (%) 6%
Previous coronary artery bypass grafting (%) 5%
Abbreviations and Acronyms
CI ¼ confidence interval
HR ¼ hazard ratio
TEVAR ¼ thoracic endovascular aortic repair
Aortic Symposium 2010 Czerny et alStatistical Analysis
Continuous data are presented as the median and interquartile range
(range from the 25th to the 75th percentiles). Discrete data are given as
counts and percentages. Comparisons of continuous data were performed
by Mann–Whitney U tests, and groups of categoric data were compared
by c2 tests. Spearman test was applied for correlations. Kaplan–Meier sta-
tistics were used to calculate survivals and freedoms from valve-related
complications, and the log-rank test was used to determine intergroup differ-
ences. Finally, we used multivariate Cox regression analysis to identify in-
dependent predictors of early and late endoleaks and of survival. Regression
diagnostics and overall model fit were determined according to standard
procedures. Calculations were performed with SPSS for Mac OsX (version
16.0; SPSS Inc, an IBM Company, Chicago, Ill).RESULTS
In-Hospital Mortality and Neurologic Injury
Overall in-hospital mortality was 5.3%. Mortality among
elective patients was 4.0%, whereas mortality among
emergency patients was 15.3%. Transient neurologic injury
could be observed in 2.6%. Symptomatic spinal cord injury
was not observed in this series.Need For Rerouting Procedures and Extent of
Aneurysms
Previous rerouting procedures were necessary in 51%.
Table 3 depicts types and numbers. Tables 4 and 5 depict
origins and extents of aneurysms.Early Type I and III Endoleaks and Need for
Reinterventions
Early type I and III endoleaks were observed in 25.6%.
Assisted early endoleak rate was 7.9%. The remaining
endoleaks required a watchful waiting strategy. Among
those with an observational approach, 2 patients underwent
late surgical conversion.TABLE 2. Types of stent–grafts used
No.
Gore Excluder 27%
Medtronic Talent 20%Early Type II Endoleaks and Need for
Reinterventions
Early type II endoleaks were observed in 4.4%. In 3.5%,
an increase of maximum aneurysm diameter could be ob-
served. Two patients eventually had to undergo late surgical
conversion because of a lack of other options.Gore TAG 19%
Bolton Relay 16%
Medtronic Valiant 14%
Endomed 3%
Jotec Evita 1%Late Type I and III Endoleaks and Need for
Reinterventions
Late type I or III endoleaks occurred in 11.5%. Among
affected patients, 46% were treated with reoperative TE-S180 The Journal of Thoracic and Cardiovascular SurVAR, 46% had to be observed, and 8% had to undergo
late surgical conversion.Endotension and Need for Reinterventions
Endotension was observed in 2 patients. Both patients un-
derwent successful reoperative TEVAR.Survival and Aorta-Related Survival
The mean follow-up period was 54  38 months (range,
5–144 months). Overall actuarial survivals were 86%, 60%,
and 42% at 1, 5, and 10 years, respectively (Figure 1).
Aorta-related actuarial survivals were 94%, 90%, and 83%
at 1, 5, and 10 years, respectively (Figure 2).Cox Regression Analysis
Early endoleak formation (Table 6). A higher number of
prostheses used (hazard ratio [HR], 5.38; 95% confidence
interval [CI], 1.68–42.37) turned out to be the only indepen-
dent risk factor for early endoleak formation. Involvement of
the aortic arch (HR, 0.41; 95% CI, 0.11–1.57) and an earlier
year of TEVAR (HR, 0.58; 95% CI, 0.14–2.51) did not
show any influence on early endoleak formation.
Late endoleak formation (Table 7). A higher number of
prostheses used also turned out to be the only independent
predictor of late endoleak formation (HR, 8.49, 95% CIgery c December 2010
TABLE 3. Types of rerouting procedures performed
Subclavian transposition 30%
Double transposition 42%
Entire arch transposition 23%
Other arch rerouting procedures 5%
TABLE 5. Extent of aneurysms (according to frequency)
Thoracoabdominal transition 29%
Below thoracoabdominal transition 23%
Distal third of descending aorta 23%
Proximal third of descending aorta 13%
Mid third of descending aorta 12%
Czerny et al Aortic Symposium 20101.09–66.06). Neither involvement of the aortic arch (HR,
0.32; 95% CI, 0.09–1.09) nor an earlier year of TEVAR
(HR, 2.15; 95% CI, 0.72–6.46) showed any influence on
early endoleak formation.
Survival (Table 8). Female sex turned out to be an indepen-
dent predictor of survival (HR, 0.35; 95% CI, 0.13–0.99).
Furthermore, lack of arch involvement (HR, 0.21; 95% CI,
0.05–0.08) as well as a higher number of prostheses used
independently affected survival (HR, 7.95; 95% CI, 1.36–
46.58).DISCUSSION
In-hospital mortality was pleasantly low among elective
patients, underlining the limited physiologic burden of the
procedure. Among emergency patients, mortality was higher
as expected, most likely because inflammation, hemody-
namic compromise, and resulting problems of the acute
state, such as renal failure, are limiting.14 We observed
a very low incidence of central neurologic injury, with 4
clinically regressive left-sided lesions. This finding is impor-
tant, because it confirms our policy of routine subclavian–
carotid transposition in each elective case to preserve left
posterior cerebellar circulation and thereby also maintain
spinal cord perfusion, with events occurring exclusively in
patients with impaired left subclavian perfusion.15 With
respect to cerebrospinal fluid drainage, we do follow a dis-
tinct strategy, which has been described in detail previ-
ously.16 Cerebrospinal fluid drainage was not routinely
applied because of the necessity of maintaining continuing
antiplatelet therapy related to severe cardiovascular comor-
bidities in many patients. Because of our previous experi-
ence with high-risk patients, we concluded that extensive
stent–graft coverage of the entire thoracic aorta can be
performed safely in most patients when 3 of 4 spinal cord–
supplying vascular territories are preserved.16
Furthermore, the issue of suitability for conventional sur-
gery warrants discussion, because this remains a subjective
decision of the individual treating physician. Even now,
there is occasional dissent within our group regarding thisTABLE 4. Origin of aneurysms (according to frequency)
Proximal third of descending aorta 48%
Distal aortic arch 22%
Mid third of descending aorta 17%
Proximal aortic arch 6%
Mid aortic arch 5%
Distal third of descending aorta 2%
The Journal of Thoracic and Carddecision. Summarizing, multisegmental thoracic aortic dis-
ease, which reflects a higher disease burden, is grounds for
unsuitability in combination with at least 1 of the following
factors: need for previous or recurring cardiac surgery before
aortic surgery, active malignancy, chronic obstructive pul-
monary disease with a forced expiratory volume in 1 second
less than 11, and frailty, which has no clear definition in this
setting and therefore remains subjective. Nevertheless, the
underlying aortic disease has to be the limiting factor for
the life expectancy in such cases. Otherwise, we would treat
computed tomographic scans and not patients.
Previous work has shown that the length of the landing
zone is among the most important independent predictors
of early and late endoleak formation.17,18 Stimulated by
this finding, we have further expanded our policy of
creating sufficient landing zones. We were thus able to
eliminate the length of the landing zone as an independent
risk factor for endoleak formation. Recent work has also
confirmed that the fact of arch rerouting per se does not
increase cumulative risk.19 It might be of further interest to
note that more than half of all patients required transposi-
tions to create sufficient landing zones, underlining the find-
ing that the simple, unisegmental atherosclerotic descending
aortic aneurysm is the exception, not the rule.
Assisted primary endoleak rate was acceptably low not
only with endoleak treatment but also with a tailored watch-
ful waiting strategy. It is a matter of speculation which endo-
leaks may resolve spontaneously and which should be
treated immediately. Nevertheless, physicians should be
aware that a huge (and especially proximal) type I endoleak
aggravates the natural course of the underlying disease, be-
cause blood pressure in the blind sac may be substantially
higher than that in downstream aortic segments. Early type
III endoleaks mostly result from insufficient overlapping
zones, as well as from disregarding anatomy, especially
steep angles at the thoracoabdominal transition, and should
be avoidable in most cases today.17,18
Interestingly, the percentage of type II endoleaks requir-
ing treatment was high. This is in contrast to previous find-
ings, not only for TEVAR but also for endovascular aortic
repair in general. To our impression, the segment as well
as the source of retrograde filling of the aneurysmal sac is
of importance. Both conversions to open surgery started
with retrograde filling of the aneurysmal sac from an over-
stated left subclavian artery. For surgical conversion, an en-
largement of not only the sac but also the proximal neck
needed to be observed. In fact, in TEVAR as well asiovascular Surgery c Volume 140, Number 6S S181
FIGURE 1. Survival. pts, Patients.
Aortic Symposium 2010 Czerny et alendovascular aortic repair in general, isolated small intercos-
tal arteries have no significant effect in time.17,20
Previous work from our group suggested that early endo-
leak formation is not associated with late endoleak forma-FIGURE 2. Aorta-related
S182 The Journal of Thoracic and Cardiovascular Surtion.17 This is confirmed by this analysis, because no
patient with a successfully treated early endoleak showed
a late endoleak with the same cause. This finding does, how-
ever, underline the necessity for lifelong surveillance,survival. pts, Patients.
gery c December 2010
TABLE 6. Cox proportional hazards model: Early endoleak formation
Variable
Hazard
ratio
95% Confidence
interval
Age>75 y 0.45 0.15–1.36
Female sex 1.31 0.45–3.80
Operative year after 2001 0.58 0.14–2.51
Emergency 2.19 0.14–2.51
Arch involvement 0.41 0.11–1.57
Proximal landing zone (cm) 0.76 0.48–1.20
No. of prostheses used (higher) 5.38 0.68–42.37
TABLE 8. Cox proportional hazards model: Survival
Variable
Hazard
ratio
95% Confidence
interval
Age>75 y 2.03 0.84–4.91
Female sex 0.35 0.13–0.99
Suitable for open repair 0.38 0.07–2.15
Operative year after 2001 0.82 0.27–2.50
Emergency 0.71 0.13–3.99
No arch involvement 0.21 0.05–0.08
No. of prostheses used (higher) 7.95 1.36–46.58
Early endoleak formation 0.50 0.12–2.13
Late endoleak formation 0.61 0.17–2.14
Surgical conversion 1.78 0.17–19.13
Czerny et al Aortic Symposium 2010because late endoleaks or aortic pathology in different seg-
ments requiring treatment may develop in time, such as
type V endoleaks that should no longer be seen with recent
technology.21
Early endoleak formation, like late endoleak formation,
was independently predicted by a higher number of pros-
theses used. This finding seems likely to be reproducible,
because a higher number of prostheses may decrease lat-
eral stability, especially in angulated anatomy, and may
thereby predispose toward early and late failure.17 In con-
sequence, the industry now provides physicians with pros-
theses as long as 250 mm, which may well serve to solve
this problem.
Aorta-related survival, which should be regarded as
among the strongest parameters of success or failure of
any aortic therapy, was excellent. Survival itself was inde-
pendently predicted by female sex, a higher number of pros-
theses, and the fact that the aortic arch was not involved in
the aneurysm. Women had a similar age distribution to
men in this series, which may help to explain this finding.
Additionally, the incidences of both coronary artery disease
and peripheral arterial occlusive disease were lower among
women. A higher number of prostheses predicted adverse
outcome, perhaps because prosthesis number reflects the
multisegmental nature of the disease and is thereby directly
related to the disease burden. The fact that noninvolvement
of the arch turned out to favorably influence survival may be
related to the same underlying cause.
In summary, aorta-related survival is excellent among
patients undergoing TEVAR for atherosclerotic aneurysms
involving the descending aorta. Lifelong surveillance re-TABLE 7. Cox proportional hazards model: Late endoleak formation
Variable
Hazard
ratio
95% Confidence
interval
Age>75 y 2.03 0.84–4.91
Female sex 0.49 0.18–1.32
Operative year after 2001 2.15 0.72–6.46
Emergency 0.49 0.10–2.31
Arch involvement 0.32 0.09–1.09
Proximal landing zone (cm) 0.64 0.33–1.26
No. of prostheses used (higher) 8.49 1.09–66.06
The Journal of Thoracic and Cardmains mandatory, because early and late failure–although
not common–must still be considered. TEVAR in this
group of patients remains attractive and now has proven
durability.
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